血液透析患者死亡风险专项管理的临床应用价值分析

Clinical Value Analysis of Special Management of Death Risk of Hemodialysis Patients

目的讨论血液透析患者在治疗期间接受死亡风险专项管理,以降低死亡率的临床效果,并总结导致该类患者死亡的原因。方法选2014年12月~2016年12月在本院接受血液透析治疗的患者110例,随机分为对照组和观察组,平均每组55例。对照组实施常规透析管理;观察组实施死亡风险专项管理。对比两组患者在血液透析治疗期间死亡例数、住院接受血液透析治疗时间、家属对透析期间管理模式的满意度。结果观察组患者在血液透析治疗期间仅有1例死亡,少于对照组的7例,差异显著(P<0.05);住院接受血液透析治疗时间短于对照组,组间差异显著(P<0.05);家属对透析期间管理模式的满意度达到94.5%,高于对照组的81.8%,差异显著(P<0.05)。结论血液透析患者在治疗期间综合考虑导致其死亡的危险因素,实施死亡风险专项管理,可以有效降低死亡率,保证透析安全,使患者转归更加理想。

Objective To discuss the clinical effect of hemodialysis patients with special management of death risk during treatment to reduce mortality and to summarize the reasons for the death of these patients.Methods110patients with hemodialysis in our hospital from December2014to December2016were randomly divided into the control group and the observation group,with an average of55patients in each group.The control group received routine dialysis management,and the observation group carried out the special management of the risk of death.Compare the two groups of patients during hemodialysis treatment,the number of deaths,hospitalization hemodialysis treatment time and the satisfaction of the family members in the dialysis period management model.Results Only1patient died during the hemodialysis treatment in the observation group,less than7cases in the control group,and the difference was significant(P<0.05).The hospital hemodialysis treatment time of the observation group was shorter than that of the control group,significant difference are between groups(P<0.05).The satisfaction of the family members of the management mode during dialysis period reached94.5%,higher than the control group81.8%,and the difference was significant(P<0.05).Conclusion Hemodialysis patients in the treatment of a comprehensive consideration of the risk factors leading to their deaths,the implementation of special management of risk of death,can effectively reduce mortality,ensure dialysis safety,so that the outcomes of patients are more ideal.